| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 05/24/2012 | WO2012066479A1 Use of quinolinone derivatives as a research tool |
| 05/24/2012 | WO2012066331A1 Cross protective epitopes of aspergillus fumigatus and candida albicans |
| 05/24/2012 | WO2012066302A1 Biomarkers |
| 05/24/2012 | WO2012066260A1 Determination of the thrombogenic power of human immunoglobulins |
| 05/24/2012 | WO2012066235A1 Device and method for immunotrials |
| 05/24/2012 | WO2012066161A1 Glutamyl aminopeptidase as a marker of renal damage |
| 05/24/2012 | WO2012066140A1 Method for monitoring physical training in healthy and diseased individuals |
| 05/24/2012 | WO2012066057A1 Prediction of a small-for-gestational age (sga) infant |
| 05/24/2012 | WO2012066055A1 Device for analyzing the effects of at least one parameter relating to a volatile substance |
| 05/24/2012 | WO2012066034A1 Method and apparatus for detecting foam on a liquid surface in a vessel |
| 05/24/2012 | WO2012066003A1 Compound for the covalent attachment of the chemiluminescent probe n-(4-aminobutyl)-n-ethylisoluminol (abei) to target molecules and uses thereof |
| 05/24/2012 | WO2012065983A1 A method for assessing alzheimer's disease |
| 05/24/2012 | WO2012065912A1 Automatic immunoassay for biogenic amines |
| 05/24/2012 | WO2012065720A1 Cell-based screening assay for inhibitors of net formation |
| 05/24/2012 | WO2012065696A1 A guided structured testing kit |
| 05/24/2012 | WO2012065330A1 Test method of moisturizing properties of tobacco |
| 05/24/2012 | WO2012049465A8 Assay device |
| 05/24/2012 | WO2012047869A3 Sensors and devices containing ultra-small nanowire arrays |
| 05/24/2012 | WO2012046006A3 Cutaneous squamous cell carcinoma target sequences |
| 05/24/2012 | WO2012044387A3 Methods and compositions for detection of analytes |
| 05/24/2012 | WO2012042226A3 Biochemical analysis apparatus using nanopores |
| 05/24/2012 | WO2012027617A3 Systems and methods for detecting normal levels of bacteria in water using a multiple angle light scattering (mals) instrument |
| 05/24/2012 | WO2012019201A3 Tamper evident point of containment, inventory and accountability system and method |
| 05/24/2012 | WO2012019099A3 Follistatin-like-protein-1 as a biomarker for inflammatory disorders |
| 05/24/2012 | WO2012019000A3 Biomarkers for the identification monitoring and treatment of ovarian cancer |
| 05/24/2012 | WO2012012797A3 Methods for isolating and using a subset of cd8 t-cells that are resistant to cyclosporin |
| 05/24/2012 | WO2012012704A3 Methods of detecting kidney-associated diseases or conditions |
| 05/24/2012 | WO2012011778A3 Cancer diagnosis kit and pharmaceutical composition for prevention or treatment of cancer |
| 05/24/2012 | WO2012011777A3 Kit for diagnosing colorectal cancer and pharmaceutical composition for prevention or treatment of colorectal cancer |
| 05/24/2012 | WO2012009547A3 Biomarkers for diagnosis of transient ischemic attacks |
| 05/24/2012 | WO2012009499A3 Assessing thyroid neoplasms and treating cancer |
| 05/24/2012 | WO2012006497A3 Mu opioid receptor agonist analogs of the endomorphins |
| 05/24/2012 | WO2011156656A3 Multiplex immune effector molecule assay |
| 05/24/2012 | WO2011140093A9 Detection and monitoring of nonalcoholic fatty liver disease |
| 05/24/2012 | WO2011059721A9 Protein and lipid biomarkers providing consistent improvement to the prediction of type 2 diabetes |
| 05/24/2012 | WO2011031736A3 Methods of identifying anti-inflammatory compounds |
| 05/24/2012 | WO2009131971A3 System and method for testing heat exchange system for heat exchange catheter |
| 05/24/2012 | US20120130584 System and method for quantifying the presence of components in the exhaust of commercial and/or heavy-duty vehicles |
| 05/24/2012 | US20120130350 Detection and treatment of autoimmune disorders |
| 05/24/2012 | US20120130343 Tissue penetration device |
| 05/24/2012 | US20120129869 Phosphorylation and mutations of anaplastic lymphoma kinase as a diagnostic and therapeutic target in lung cancer |
| 05/24/2012 | US20120129835 Schizophrenia methods and compositions |
| 05/24/2012 | US20120129788 Phosphodiesterase 4d7 as marker for malignant, hormone-sensitive prostate cancer |
| 05/24/2012 | US20120129777 Methods for Treating Bleeding Disorders Using Sulfated Polysaccharides |
| 05/24/2012 | US20120129764 Influenza a and b virus replication-inhibiting peptides |
| 05/24/2012 | US20120129725 Nucleic acid nano-biosensors |
| 05/24/2012 | US20120129723 System and method for carrying out multiple binding reactions in an array format |
| 05/24/2012 | US20120129721 Urinary gm2 activator protein as a marker of acute renal failure or the risk of developing acute renal failure |
| 05/24/2012 | US20120129712 Antibodies directed to tra antigens, and methods of production, screening and analysis of said antibodies, as well as methods of analysis of stem cells and cancer cell |
| 05/24/2012 | US20120129711 Biomarkers for the prognosis and high-grade glioma clinical outcome |
| 05/24/2012 | US20120129710 Methods for producing members of specific binding pairs |
| 05/24/2012 | US20120129709 Sensor for detection of nucleic acid |
| 05/24/2012 | US20120129705 Diagnostic markers for determining the predisposition to the development of cervical cancer and oligonucleotides used for the determination |
| 05/24/2012 | US20120129704 Generation of uniform fragments of nucleic acids using patterned substrates |
| 05/24/2012 | US20120129272 Lateral flow assay systems and methods |
| 05/24/2012 | US20120129271 Longitudinal assay |
| 05/24/2012 | US20120129270 Vesicular system and uses thereof |
| 05/24/2012 | US20120129267 Sulfur breakthrough detection assembly for use in a fuel utilization system and sulfur breakthrough detection method |
| 05/24/2012 | US20120129266 Method of detecting oxides of nitrogen |
| 05/24/2012 | US20120129265 New biomarkers for assessing kidney diseases |
| 05/24/2012 | US20120129248 Assay tools and methods of use |
| 05/24/2012 | US20120129202 Composition for assaying glycated proteins |
| 05/24/2012 | US20120129200 Prodefensin-a6 assay method for the in vitro diagnosis of colorectal cancer |
| 05/24/2012 | US20120129199 Compositions, kits and methods for in vitro antigen presentation, assessing vaccine efficacy, and assessing immunotoxicity of biologics and drugs |
| 05/24/2012 | US20120129198 Novel methods for the assay of troponin i and t and complexes of troponin i and t and selection of antibodies for use in immunoassays |
| 05/24/2012 | US20120129197 Immunomodulation of Functional T Cell Assays for Diagnosis of Infectious or Autoimmune Disorders |
| 05/24/2012 | US20120129196 Highly sensitive monoclonal antibody residual detection assay |
| 05/24/2012 | US20120129195 Method of quick laboratory diagnosis if illnesses based on the discovery of specific proteins and equipment for its implementation |
| 05/24/2012 | US20120129194 Visible Detection of Microorganisms |
| 05/24/2012 | US20120129192 Apparatus and Methods for Detection of Tumor Cells in Blood |
| 05/24/2012 | US20120129191 Cocktail antibody, determination kit and determination method for determining histological type of carcinoma |
| 05/24/2012 | US20120129189 Methods of Controlling Cell Proliferation |
| 05/24/2012 | US20120129188 Circulating cytochrome c as biomarker of reperfusion injury and responsiveness to mitochondrial targeted interventions |
| 05/24/2012 | US20120129187 Diagnostical use of peroxiredoxin 4 |
| 05/24/2012 | US20120129186 Devices and methods for the diagnosis and treatment of wounds using biomarkers |
| 05/24/2012 | US20120129185 Methods and compositions for diagnosing ankylosing spondylitis using biomarkers |
| 05/24/2012 | US20120129184 Systemic carnitine deficiency gene and uses thereof |
| 05/24/2012 | US20120129183 Methods and kits for isolating placental derived microparticles and use of same for diagnosis of fetal disorders |
| 05/24/2012 | US20120129179 Scn5a splicing factors and splice variants for use in diagnostic and prognostic methods |
| 05/24/2012 | US20120129178 Genomic polymorphism for predicting therapeutic response |
| 05/24/2012 | US20120129175 Method for renal disease diagnosis and prognosis using annexin a1 and rab23 as markers |
| 05/24/2012 | US20120129172 Method for selecting clone of induced pluripotent stem cells |
| 05/24/2012 | US20120129168 Tumor marker and use thereof |
| 05/24/2012 | US20120129167 Truncated cd20 protein, deltacd20 |
| 05/24/2012 | US20120129162 Cell culture system for determining the sensitizing, allergenic and/or irritating effect of a substance |
| 05/24/2012 | US20120129157 Methods and Devices for Rapid Detection and Identification of Live Microorganisms by Aptamers and/or Antibodies Immobilized on Permeable Membranes |
| 05/24/2012 | US20120129150 Particles embedded in a porous substrate for removing target analyte from a sample |
| 05/24/2012 | US20120128838 System and method for lean recovery using non invasive sensors |
| 05/24/2012 | US20120128708 Diagnostic mycobacterium tuberculosis test |
| 05/24/2012 | US20120128705 C6orf167 peptides and vaccines containing the same |
| 05/24/2012 | US20120128702 Novel biomarkers for a prediction of the outcome of an immunotherapy against cancer |
| 05/24/2012 | US20120128697 NOTCH Inhibition in the Treatment or Prevention of Atherosclerosis |
| 05/24/2012 | US20120128695 Teneurin c-terminal associated peptides (tcap) and methods and uses thereof |
| 05/24/2012 | US20120128690 Methods for determining agents that treat or prevent obesity and/or obesity related diseases and methods for treatment therewith |
| 05/24/2012 | US20120128682 Apolipoprotein l- i variants and their use |
| 05/24/2012 | US20120128681 Anti-CK8 Antibodies To Be Used For Treating Colorectal Cancers And Identifying Metastatic And/Or Invasive Phenotypes |
| 05/24/2012 | US20120128680 Biomarker antibody and diagnosis device for detecting certain autoimmune diseases |
| 05/24/2012 | US20120128678 Diagnosis and treatment of cancer using anti-tmprss11e antibody |
| 05/24/2012 | US20120128677 Pancreatic cancer targets and uses thereof |
| 05/24/2012 | US20120128676 Muc1 antibodies |